- Company Overview for TOUCH CREATIVE DESIGN LIMITED (05938761)
- Filing history for TOUCH CREATIVE DESIGN LIMITED (05938761)
- People for TOUCH CREATIVE DESIGN LIMITED (05938761)
- Charges for TOUCH CREATIVE DESIGN LIMITED (05938761)
- Registers for TOUCH CREATIVE DESIGN LIMITED (05938761)
- More for TOUCH CREATIVE DESIGN LIMITED (05938761)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 Jan 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/20 | |
17 Jan 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/20 | |
12 Jan 2022 | TM01 | Termination of appointment of Gregory Spencer Caswill as a director on 14 December 2021 | |
12 Jan 2022 | TM01 | Termination of appointment of Brian Alexander Hepburn as a director on 14 December 2021 | |
11 Jan 2022 | AP01 | Appointment of Mr Joshua Hollis Korth as a director on 14 December 2021 | |
07 Oct 2021 | CS01 | Confirmation statement made on 18 September 2021 with no updates | |
24 Sep 2021 | TM01 | Termination of appointment of John David Gillie as a director on 10 August 2021 | |
03 Oct 2020 | AA | Audit exemption subsidiary accounts made up to 31 December 2019 | |
03 Oct 2020 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/19 | |
03 Oct 2020 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/19 | |
03 Oct 2020 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/19 | |
18 Sep 2020 | CS01 | Confirmation statement made on 18 September 2020 with updates | |
18 Sep 2020 | PSC07 | Cessation of Alligent Biopharm Consulting Limited as a person with significant control on 29 May 2019 | |
18 Sep 2020 | PSC02 | Notification of Alligent Biopharm Consulting Limited as a person with significant control on 29 May 2019 | |
18 Sep 2020 | PSC02 | Notification of Envision Pharma Holdco Limited as a person with significant control on 29 May 2019 | |
18 Sep 2020 | PSC07 | Cessation of Envision Pharma Bidco Limited as a person with significant control on 29 May 2019 | |
18 Sep 2019 | CS01 | Confirmation statement made on 18 September 2019 with no updates | |
12 Jul 2019 | AA | Audit exemption subsidiary accounts made up to 31 December 2018 | |
12 Jul 2019 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/18 | |
12 Jul 2019 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/18 | |
12 Jul 2019 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/18 | |
05 Oct 2018 | AA | Audit exemption subsidiary accounts made up to 31 December 2017 | |
05 Oct 2018 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/17 | |
24 Sep 2018 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/17 | |
24 Sep 2018 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/17 |